Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksN4 Pharma Plc Share News (N4P)

Share Price Information for N4 Pharma Plc (N4P)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.75
Bid: 0.70
Ask: 0.80
Change: 0.00 (0.00%)
Spread: 0.10 (14.286%)
Open: 0.75
High: 0.75
Low: 0.75
Prev. Close: 0.75
N4P Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EARNINGS SUMMARY: Franchise Brands blooms; Tlou Energy loss widens

Thu, 09th Mar 2023 14:32

(Alliance News) - The following is a round-up of earnings by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

Franchise Brands PLC - Manchester-based owner of ChipsAway, Willow Pumps and Metro Rod brands - Pretax profit in 2022 jumps 78% to GBP10.3 million from GBP5.8 million in 2021, boosted by business to business division. Revenue grows 72% to GBP99.2 million from GBP57.7 million. Proposes final dividend of 1.1 pence per share, up from 0.9p a year ago. Total dividend is 2.0p per share, up 33% from 1.5p. Net cash as at December 31 grows to GBP8.0 million from GBP6.5 million. Executive Chair Stephen Hemsley says: "The excellent momentum in the B2B businesses has continued in 2023 to date, as we capture the defensive growth opportunities afforded by the group's mostly essential services, strong leadership positions in its chosen markets, and reputation for high quality, reliable services among its diversified client base. We look forward with confidence to expanding the business organically and by seeking further earnings-enhancing acquisitions."

----------

Hansard Global PLC - Isle of Man-based long-term savings provider - In six months to December 31, pretax profit grows to GBP3.1 million from GBP1.9 million a year prior. Maintains interim dividend of 1.8p per share. Net asset value per share as at December 31 falls to 15.6p from 16.7p a year ago. Anticipates sales of long-term savings products to continue to be impacted by global economic headwinds, but adds: "however, we are confident that our new product pipeline will lead to increased sales and long term growth in the business."

----------

N4 Pharma PLC - Derby, England-based pharmaceutical company focused on developing Nuvec, a delivery system for vaccines and cancer treatments - In 2022, pretax loss narrows to GBP1.2 million from GBP1.8 million in 2021. Research & development costs reduce to GBP577,525 from GBP1.2 million. Company does not make revenue in 2022 or 2021. Notes delays of research grade materials due to global shortages. Says work is underway, with full results expected by the end of the second quarter of 2023.

----------

Seraphim Space Investment Trust PLC - London-based space technology investment company - Net asset value per share as at December 31 declines 7.2% to 92.74 pence per share from 99.97p at June 30. Company does not expect to recommend payouts in the near future due to its focus on achieving capital growth. In its outlook, notes innovation of Western economies regarding the impact of Russia's war in Ukraine. Chair Will Whitehorn says: "The investment manager is actively engaged with numerous investment prospects, carefully selecting those with a strong growth premise and offer the highest returns for shareholders. It is taking a cautious approach to the allocation of cash between supporting existing portfolio companies, making new investments, and managing the company's working capital until the market improves and more capital can be raised."

----------

Tlou Energy Ltd - Brisbane, Australia-based power project developer with large gas field in Botswana - In the six months to December 31, pretax loss widens to AUD2.2 million from AUD1.3 million a year ago. Employee benefits expense increases to AUD564,644 from AUD320,901. Posts an interest expense of AUD296,013 compared to none a year ago. Expenses classified as other widen to AUD1.0m million from AUD585,650. Expects work on purpose-built operations facility for 10 megawatt development at Lesedi, Botswana to be completed during 2023, with potential annual generation of about USD10 million in revenue from the project.

----------

Town Centre Securities PLC - Leeds, England based property investment and car parking operator - Net asset value as at December 31 is virtually flat at 314 pence per share, compared to 313p a year ago. It is down 7.9% from 341p at June 30, 2022. Maintains interim dividend at 2.5p per share. EPRA net tangible assets per share as at June 30 falls to 306p from 333p a year ago. Looking ahead, says that trading performance seen in the first half of financial year 2023 is performing into the opening months of calendar year 2023, with rent collections robust at 99% of amounts invoiced at the last quarter now collected. "The momentum in our car parks recovery has continued through 2022 however for those car parks that are particularly reliant on office workers, this recovery remains slow," it adds.

----------

By Tom Budszus, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
8 Feb 2019 13:18

N4 Pharma Raises GBP1.1 Million In Share Placing To Fund Nuvec System (ALLISS)

LONDON (Alliance News) - N4 Pharma PLC on Firday said it raised GBP1.1 million in a placing of 10.5 million shares at 10 pence each.N4 Pharma shares were trading down 18% at 10.10p each on

Read more
8 Feb 2019 12:00

N4 Pharma raises £1.05m in placing to advance vaccine delivery system

(Sharecast News) - Specialist pharmaceutical company N4 Pharma said on Friday that it has raised £1.05m before expenses in a placing of 10.5m new ordinary shares to fund its vaccine delivery system.

Read more
20 Dec 2018 15:06

N4 Pharma extends 'Nuvec' licence agreement with Aussie university firm

(Sharecast News) - Specialist pharmaceutical company N4 Pharma has extended the terms of its licence agreement with UniQuest - a University of Queensland company - for the exploitation of its novel delivery system 'Nuvec' on Thursday.

Read more
28 Nov 2018 11:30

N4 Pharma bears more good news on its Nuvec particles

(Sharecast News) - Specialist pharmaceutical company N4 Pharma updated on the latest key research findings for its 'Nuvec' delivery system on Wednesday.

Read more
28 Nov 2018 11:20

N4 Pharma Shares Boosted By Positive Nuvec System Results

LONDON (Alliance News) - N4 Pharma PLC shares were up on Wednesday after encouraging research on its Nuvec delivery system.Shares in the pharma company were up 26% at 10.74 pence on Nuvec a

Read more
5 Nov 2018 10:57

WINNERS & LOSERS SUMMARY: Micro Focus Rises On Outlook And Buyback

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.----------FTSE 100 - WINNERS----------Micro Focus up

Read more
29 Oct 2018 11:32

N4 Pharma pleased with latest test results on 'Nuvec'

(Sharecast News) - Specialist pharmaceutical company N4 Pharma updated the market on the latest key research findings for its 'Nuvec' delivery system on Monday, reporting that the Nuvec particles had a "clear adjuvant effect" to help deliver a level of immune response for both the mRNA and pDNA OVA antigens, comparable to that of existing delivery systems.

Read more
29 Oct 2018 10:51

WINNERS & LOSERS SUMMARY: HSBC Rises After Upbeat Third Quarter

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.----------FTSE 100 - WINNERS----------HSBC,

Read more
29 Oct 2018 09:46

N4 Pharma Shares Rise Following Positive Research Results For Nuvec

LONDON (Alliance News) - Shares rose in N4 Pharma PLC on Monday as a key research study demonstrated positive results for the company's Nuvec delivery system.Shares in the vaccine and a

Read more
2 Oct 2018 12:08

N4 Pharma Commissions Research Programme With Gowans Laboratory

LONDON (Alliance News) - N4 Pharma PLC said Tuesday it commissioned a research program with the Gowans laboratory in the University of Adelaide to investigate its Nuvec system's potential to a

Read more
24 Sep 2018 10:48

WINNERS & LOSERS SUMMARY: Thomas Cook Slumps After Profit Warning

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.----------FTSE 100 - WINNERS----------Sky,

Read more
20 Sep 2018 10:30

N4 Pharma To Close Generic Unit After Failed Trials; Loss Narrows

LONDON (Alliance News) - Shares in N4 Pharma PLC dropped on Thursday as the company said it will close its Generic unit after the failure of Sildenafil trials.Shares in the pharmaceutical a

Read more
20 Sep 2018 10:30

WINNERS & LOSERS SUMMARY: Rio Tinto Up On Plan To Return Sale Proceeds

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Thursday.----------FTSE 100 - WINNERS----------Rio up 1.9%.

Read more
20 Sep 2018 09:49

N4 Pharma calls it a day on generics division, losses widen

(Sharecast News) - After undertaking a strategic review, N4 Pharma directors have decided to discontinue further development of Sildenafil and shutter the rest of its generics division.

Read more
9 Jul 2018 10:08

WINNERS & LOSERS SUMMARY: Centamin Falls After Gold Production Drops

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.----------FTSE 100 - WINNERS----------Just up 2.4%.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.